Digital Therapeutics Market Size, Trends, Growth, Consumption, Revenue, Industry Report 2021-2030

The global Digital Therapeutics market size is expected to be worth around US$ 29.1 billion by 2030, according to a new report by Vision Research Reports.

The global Digital Therapeutics market size was valued at US$ 4.5 billion in 2020 and is anticipated to grow at a CAGR of 33.1% during forecast period 2021 to 2030.

Growth Factors

The key drivers for this growth include increasing incidence of chronic diseases, digitization, demand for innovative and affordable healthcare, and government initiatives.

Digital health went from novel to necessity during 2020. It swept through almost every healthcare domain as adoption peaked, accelerated by the COVID-19 pandemic. This included telehealth, telemedicine, digital pathology, triage solutions, mhealth, as well as digital therapeutics. Omada Health, Inc., a digital therapeutics provider, leveraged the gaps in care due to COVID-19 to provide extra support and guidance from its licensed specialists to those who had their doctor’s appointments deferred indefinitely. The company also helped primary care providers, therapists, endocrinologists, and cardiologists convert their practices to telehealth through enhanced education, psychosocial support, and remote monitoring.

Get the sample pages of report@ https://www.visionresearchreports.com/report/sample/37632

In response to COVID-19 and its repercussions on mental health, the FDA released guidelines expanding and promoting the scope of digital health therapeutic devices for mental health conditions. Rising initiatives by public and private players is another factor expected to propel the market growth. For instance, in June 2020, Akili Interactive Labs, Inc. received the CE mark for its digital therapeutic software for the treatment of ADHD called EndeavorRx.

With an increase in internet usage and dependency on smartphones, digital therapeutics is set to register continued growth over the forecast period. This is owing to increased demand for creative and innovative treatment options that could be used remotely by patients. In February 2021, SilverCloud partnered with Cerner Corporation to integrate its virtual mental health platform with the latter’s electronic health records. With this, SilverCloud intended to scale the delivery of evidence-based mental health treatment while improving patient outcomes and lowering the cost of care.

Report Highlights

The diabetes segment dominated the market for digital therapeutics and held the largest revenue share of more than 28.0% in 2020. The segment is expected to record the fastest growth during the forecast period. This growth is driven by the rising incidence of diabetes in the global population. According to the International Diabetes Federation (IDF), 463 million people were living with diabetes in 2019 and this number is expected to reach 700 million by 2045. This is estimated to boost demand for related digital therapeutics solutions. For instance, Patients suffering from diabetes require effective management, coaching, and guidance to handle symptoms like polyuria, polydipsia, and polyphagia, and medication reminders.

The obesity segment is anticipated to grab the second-largest share of the market. As per CDC’s National Center for Health Statistics prevalence of obesity in the U.S. was 42.4% in 2017 and 2018. This growing number is expected to fuel segment growth.

The patients segment dominated the market for digital therapeutics and held the largest revenue share of more than 32.0% in 2020 and is expected to register the highest CAGR during the forecast period. Patients are the primary users of therapeutic healthcare applications and programs. With the burgeoning number of patients suffering from chronic conditions, the demand for digital therapeutics is increasing.

Growth of the providers segment, on the other hand, can be attributed to more and more providers leveraging digital therapeutics to deliver and support therapies that are clinically proven, outside of a care setting, in addition to providing reliable patient engagement. Payers are also getting increasingly interested in covering digital therapeutics, and the segment has much scope for growth. Payers are encouraged to take initiatives by business models that facilitate adherence and enhance efficacy while reducing costs.

North America held the dominant share of more than 41.0% in the digital therapeutics market in 2020. This growth is attributed to the presence of key players, rising government initiatives, well-developed healthcare infrastructure, and rising prevalence of chronic health issues.

In April 2020, the U.S. FDA released guidelines to expand the availability of digital health therapeutic devices for psychiatric conditions. With this, the FDA intended to support individuals that were following home quarantine orders or practicing social distancing, without the need for in-clinic visits during the COVID-19 public health emergency. This would also ease burdens on healthcare facilities and reduce the risk of exposure to the virus.

In Asia Pacific, the market is expected to register the fastest growth rate over the forecast period, owing to two major factors: a large and comparatively younger population base that converts into a vast target base and rapid urbanization and digitization. In addition, constant reforms in countries to address the lack of proper infrastructure and maintain sustainable growth through financial inclusion are expected to benefit the market. As per India Cellular and Electronics Association 2020 report, 97.0% of the internet users across the country access the internet through mobile devices due to factors such as reduced smartphone prices, increased affordability of mobile data, rise in the number of rural users, and various Government initiatives.

Buy this premium research report, click here@ https://www.visionresearchreports.com/report/cart/37632 OR Call: +1 9197 992 333

Key Players

• Omada Health, Inc.
• WellDoc, Inc.
• 2Morrow, Inc.
• Livongo Health
• Propeller Health
• Pear Therapeutics
• Twine Health, Inc.
• Canary Health, Inc.
• Noom Health, Inc.
• Mango Health, Inc.

Market Segmentation

• Application Outlook
  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others
• End-use Outlook
  • Patients
  • Providers
  • Payers
  • Employers
  • Others
• Regional Outlook
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia

The Digital Therapeutics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Digital Therapeutics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Digital Therapeutics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Digital Therapeutics market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Digital Therapeutics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Digital Therapeutics Market, By End User

7.1. Digital Therapeutics Market, by End User Type, 2020-2030

7.1.1. Patients

7.1.1.1. Market Revenue and Forecast (2016-2030)

7.1.2. Providers

7.1.2.1. Market Revenue and Forecast (2016-2030)

7.1.3. Payers

7.1.3.1. Market Revenue and Forecast (2016-2030)

7.1.4. Employers

7.1.4.1. Market Revenue and Forecast (2016-2030)

7.1.5. Others

7.1.5.1. Market Revenue and Forecast (2016-2030)

Chapter 8. Global Digital Therapeutics Market, By Application

8.1. Digital Therapeutics Market, by Application, 2020-2030

8.1.1. Diabetes

8.1.1.1. Market Revenue and Forecast (2016-2030)

8.1.2. Obesity

8.1.2.1. Market Revenue and Forecast (2016-2030)

8.1.3. CVD

8.1.3.1. Market Revenue and Forecast (2016-2030)

8.1.4. CNS Disease

8.1.4.1. Market Revenue and Forecast (2016-2030)

8.1.5. Respiratory Diseases

8.1.5.1. Market Revenue and Forecast (2016-2030)

8.1.6. Smoking Cessation

8.1.6.1. Market Revenue and Forecast (2016-2030)

8.1.7. Others

8.1.7.1. Market Revenue and Forecast (2016-2030)

Chapter 9. Global Digital Therapeutics Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by End User (2016-2030)

9.1.2. Market Revenue and Forecast, by Application (2016-2030)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by End User (2016-2030)

9.1.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by End User (2016-2030)

9.1.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.2. Europe

9.2.1. Market Revenue and Forecast, by End User (2016-2030)

9.2.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by End User (2016-2030)

9.2.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by End User (2016-2030)

9.2.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by End User (2016-2030)

9.2.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by End User (2016-2030)

9.2.6.2. Market Revenue and Forecast, by Application (2016-2030)

9.3. APAC

9.3.1. Market Revenue and Forecast, by End User (2016-2030)

9.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by End User (2016-2030)

9.3.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by End User (2016-2030)

9.3.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by End User (2016-2030)

9.3.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by End User (2016-2030)

9.3.6.2. Market Revenue and Forecast, by Application (2016-2030)

9.4. MEA

9.4.1. Market Revenue and Forecast, by End User (2016-2030)

9.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by End User (2016-2030)

9.4.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by End User (2016-2030)

9.4.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by End User (2016-2030)

9.4.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by End User (2016-2030)

9.4.6.2. Market Revenue and Forecast, by Application (2016-2030)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by End User (2016-2030)

9.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by End User (2016-2030)

9.5.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by End User (2016-2030)

9.5.4.2. Market Revenue and Forecast, by Application (2016-2030)

Chapter 10. Company Profiles

10.1. Omada Health, Inc.

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. WellDoc, Inc.

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. 2Morrow, Inc

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Livongo Health

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Propeller Health

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Pear Therapeutics

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Twine Health, Inc.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Canary Health, Inc.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Noom Health, Inc.

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Mango Health, Inc.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Buy this premium research report, click here@ https://www.visionresearchreports.com/report/cart/37632 OR Call: +1 9197 992 333